Unlock stock picks and a broker-level newsfeed that powers Wall Street.
16.32
-0.29
(-1.75%)
At close: April 1 at 4:00:01 PM EDT
16.79
+0.47
+(2.88%)
Pre-Market: 4:26:04 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 15 | 13 |
| Avg. Estimate | -0.03 | 0.17 | 0.57 | 1 |
| Low Estimate | -0.59 | 0.09 | 0.1 | 0.34 |
| High Estimate | 0.28 | 0.35 | 1.33 | 1.88 |
| Year Ago EPS | 0.1 | 0.2 | 1.36 | 0.57 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 20 | 17 |
| Avg. Estimate | 239.34M | 263.4M | 1.06B | 1.17B |
| Low Estimate | 224.78M | 249.7M | 1.01B | 1.09B |
| High Estimate | 255M | 273.63M | 1.09B | 1.35B |
| Year Ago Sales | 205.83M | 241.96M | 957.8M | 1.06B |
| Sales Growth (year/est) | 16.28% | 8.86% | 10.87% | 9.81% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.06 | 0.18 | 0.14 | 0.22 |
| EPS Actual | 0.1 | 0.2 | 0.2 | 0.86 |
| Difference | 0.04 | 0.02 | 0.06 | 0.64 |
| Surprise % | 66.97% | 13.90% | 41.23% | 292.64% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.03 | 0.17 | 0.57 | 1 |
| 7 Days Ago | -0.02 | 0.18 | 0.66 | 1.01 |
| 30 Days Ago | 0.02 | 0.16 | 0.75 | 1.06 |
| 60 Days Ago | 0.02 | 0.14 | 0.79 | 1.14 |
| 90 Days Ago | 0.02 | 0.15 | 0.79 | 1.11 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 2 |
| Up Last 30 Days | 1 | 1 | 2 | 4 |
| Down Last 7 Days | -- | 1 | 2 | 2 |
| Down Last 30 Days | 4 | 5 | 11 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACAD | -131.94% | -15.53% | -57.97% | 74.82% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/27/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/27/2025 |
| Reiterates | Needham: Buy to Buy | 2/27/2025 |
| Initiated | Deutsche Bank: Hold | 2/11/2025 |
| Downgrade | Guggenheim: Buy to Neutral | 1/3/2025 |
| Reiterates | Needham: Buy to Buy | 11/7/2024 |
Related Tickers
RARE Ultragenyx Pharmaceutical Inc.
33.84
-6.55%
INCY Incyte Corporation
60.91
+0.59%
FOLD Amicus Therapeutics, Inc.
7.95
-2.57%
BCYC Bicycle Therapeutics plc
7.85
-7.54%
BMRN BioMarin Pharmaceutical Inc.
67.94
-3.89%
NEU.AX Neuren Pharmaceuticals Limited
10.81
-4.76%
IONS Ionis Pharmaceuticals, Inc.
27.26
-9.65%
RYTM Rhythm Pharmaceuticals, Inc.
50.00
-5.61%
SAGE Sage Therapeutics, Inc.
7.86
-1.13%
VNDA Vanda Pharmaceuticals Inc.
4.5000
-1.96%